# Removing Fallopian Tubes Dramatically Lowers Ovarian Cancer Risk
Most ovarian cancers actually originate in the fallopian tubes, not the ovaries themselves. Removing these tubes during routine gynecological surgery can reduce the risk of developing ovarian cancer by nearly 80 percent, according to research presented in medical literature.
This preventive approach, called bilateral salpingectomy, involves surgically removing both fallopian tubes while preserving the ovaries. The procedure offers women a substantial cancer reduction without the hormonal consequences of full oophorectomy, which removes the ovaries and triggers immediate menopause.
The discovery that fallopian tubes are the primary origin site shifted how clinicians think about ovarian cancer prevention. Women undergoing hysterectomy, tubal ligation, or other pelvic surgeries now have evidence supporting the removal of healthy fallopian tubes as a low-risk, high-benefit intervention.
The approach particularly benefits women not at elevated genetic risk. For those carrying BRCA mutations, standard recommendations already include removing both ovaries and tubes, typically around age 35 to 45. But for the general population, bilateral salpingectomy offers meaningful protection without the serious side effects of surgical menopause, which include hot flashes, bone loss, cardiovascular changes, and sexual dysfunction.
The challenge remains awareness. Many gynecologists and patients remain unfamiliar with this option. Women scheduled for any pelvic surgery should ask their doctors whether removing the fallopian tubes is appropriate for their situation.
The procedure takes minimal additional time during existing surgical procedures. For women already facing surgery, adding this step creates almost no extra risk while providing durable cancer protection throughout life.
This represents a rare instance where prevention works without major tradeoffs. The evidence suggests more gynecologists should routinely discuss salpingectomy